Impact of the COVID-19 lockdown on diabetes patients in Jeddah, Saudi Arabia

Impact of the COVID-19 lockdown on diabetes patients in Jeddah, Saudi Arabia
复制标题

DOI:
10.1016/j.dsx.2020.07.051
复制
发表时间:
2020-09-01
影响因子:
10
通讯作者:
Ghandoura, Lama
Ghandoura, Lama
中科院分区:
其他
文献类型:
--
作者:
Alshareef, Reem;Al Zahrani, Abdullah;Ghandoura, Lama

文献摘要

被引文献

相似文献

沙特阿拉伯,在他们遵守药物摄入量和生活习惯,和quality of life.Methods:在这个横断面,定性前瞻性研究,问卷调查通过电话管理的糖尿病患者谁参加了国民警卫队初级保健中心在吉达,沙特阿拉伯。调查包括人口统计学数据、糖尿病类型、使用的药物、合并症、药物依从性和封锁前后的日常习惯,以及使用Kessler心理困扰量表(K10)评估患者过去一个月的心理参数。数据分析采用SPSS 26软件包。结果:共纳入394例患者。所有患者均患有2型糖尿病,37.6%仅有一种合并症。76.4%的患者使用抗糖尿病单药治疗,而23.6%的患者使用联合治疗。封锁前的依从性评分(18.49 +/- 3.05)显著高于封锁后的评分(17.40 +/- 3.25)(p值
Saudi Arabia, in terms of their compliance with medication intake and lifestyle habits, and quality of life.Methods: In this cross-sectional, qualitative prospective study, a questionnaire was administered over the telephone to diabetes patients who had attended National Guard primary care centers in Jeddah, Saudi Arabia. The survey included questions on demographic data, type of diabetes, medications used, comorbidities, medication compliance, and daily habits before and after the lockdown, and those assessing patients' psychological parameters during the past month by using the Kessler Psychological Distress Scale (K10). Data analysis was performed using SPSS program version 26.Results: Totally, 394 patients participated. All of them had type 2 diabetes, and 37.6% had only one comorbidity. Antidiabetic monotherapy was used in 76.4% of the patients, while combination therapy was used in 23.6%. The compliance score before the lockdown was significantly higher (18.49 +/- 3.05) than that after it (17.40 +/- 3.25) (p-value